skip to main content

Bronchial Carcinoid — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

HardLung CancerBronchial CarcinoidSCE Medical Oncology

A 45-year-old woman with a typical bronchial carcinoid (1.5 cm, Ki-67 2%, centrally located causing recurrent haemoptysis) is discussed at the thoracic MDT. What is the primary treatment?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Parenchyma-sparing surgical resection with systematic nodal assessment

A small resectable typical central carcinoid should undergo lung-sparing anatomical resection, where feasible, with systematic nodal assessment. Anatomical lobectomy with systematic nodal assessment for every central carcinoid: lobectomy is effective but unnecessarily sacrifices parenchyma when sleeve resection is feasible. Bronchoscopic ablation with systematic nodal assessment and interval surveillance: endobronchial control does not provide definitive resection of a fit resectable patient. Stereotactic radiotherapy with endobronchial ultrasound nodal assessment: radiotherapy is principally considered when surgery is unsuitable. Somatostatin analogue with endobronchial ultrasound nodal assessment: a somatostatin analogue is not definitive local treatment for this resectable lesion.

Reference: Pure bronchoplastic resection for central endobronchial carcinoid tumours (Published May 2013): https://pubmed.ncbi.nlm.nih.gov/23628650/; NICE NG122 lung cancer: recommendations (Current NICE recommendations, accessed July 2026): https://www.nice.org.uk/guidance/ng122/chapter/Recommendations